Litigation Details for Natera, Inc. v. CareDx, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Natera, Inc. v. CareDx, Inc. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-01-13 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Plaintiff | Referred To | Christopher J. Burke |
Parties | NATERA, INC. | ||
Patents | 6,807,491; 7,727,720; 8,389,578 | ||
Attorneys | Brian E. Farnan | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Natera, Inc. v. CareDx, Inc.
Biologic Drugs cited in Natera, Inc. v. CareDx, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Natera, Inc. v. CareDx, Inc. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-01-03 | 120 | Complaint - Amended | Mar. 11 , 2013 , now Pat . No. 6,807,491 B2 10/2004 Pavlovic et al . … Among these patented inventions is U.S. Patent No. 11,111,544 (the “’544 Patent”), which CareDx…this claim for patent infringement to compel CareDx to stop infringing Natera’s patent and to compensate…are protected by a substantial patent portfolio, with over 330 patents issued or pending worldwide…and claimed in the ’544 Patent. By contrast, CareDx has used Natera’s patented cfDNA technology without | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |